Overview

19th DIA Annual Workshop for Clinical Data Management

PROGRAM OVERVIEW

Rapidly evolving regulations, risk-based monitoring (RBM), electronic data submission, electronic source and real-world evidences in clinical trials, are impacting the role of clinical data management (CDM). Adapting the shift of clinical research landscape is essential to conduct clinical research right and to get treatments to the market faster and more efficiently.

The 19th Annual Workshop in Japan for CDM will be held in Tokyo, January 2016, with a theme of "The Evolution of Clinical Data Management Capabilities" with educational content designed for all levels of professionals, from beginner to expert.

What "Evolution" does CDM need? Improved clinical research process and system are required to support real-time scientific and operational decision-makings utilizing large data. To meet these challenges and opportunities, further collaboration is needed among industry, government, and academia. CDM must draw away from conventional data managers and should lead the "Evolution" of clinical research.

This workshop is focused on translating the shift of clinical research landscape into practice and explores contemporary CDM roles and responsibilities. It will help you improve the quality of your clinical research and data management activities through educational sessions and networking opportunities among industry, government, and academia involved with global Clinical Data Management.

Featured

Want to learn more about 19th Annual Workshop in Japan for Clinical Data Management? You've come to the right site!

Program Committee

Motohide Nishi, MBA Japan Site Leader & VP Professional Services
Medidata Solutions K.K., Japan
Mariko Mizumoto Associate Director, Electronic Data System Mgt Gr, Clinical Data & Biostats Dept
Daiichi Sankyo Co., Ltd., Japan
Yumi Sugiura, MRCP Global Clinical Operations, Global Data Management and Centralized Monitoring
Bristol-Myers Squibb K.K., Japan
Manami Hashimoto Manager, Oncology Data Mgt Gr, Integrated Science & Operations Dept,Oncology Div
Novartis Pharma K.K., Japan
Yukikazu Hayashi Assistant Head of Clinical Development
A2 Healthcare Corporation, Japan
Kyoko Minamoto Medical Technologist
National Cancer Center, Japan
Yukiko Nagata Director, Biometrics
ICON Clinical Research GK, Japan
Mika Ogasawara Data Quality Lead, Biometrics and Data Management
Pfizer R&D Japan G.K., Japan
Toshiki Sugita, PhD Office of Review Management, Review Management Division
Pharmaceuticals and Medical Devices Agency (PMDA), Japan
Tomoko Sugiyama Associate Manager, Data Practice Group, Biomedical Data Sciences Department
GlaxoSmithKline K.K., Japan
Hideaki Ui, PhD Poject Professor, Director of Dpt. of Clinical research Governance
The University of Tokyo, Japan